Enhanced Luminescence-based Method for Precise Delivery of Ion Beam Therapy
Legal Citation
Summary of the Inventive Concept
An improved method for precise delivery of ion beam therapy, utilizing advanced luminescence-based markers and real-time tracking to minimize radiation damage and enhance treatment accuracy.
Background and Problem Solved
Conventional radiation therapy methods often result in unwanted radiation exposure to surrounding tissue. The original patent, 'Luminescence-based method for precise delivery of ion beam therapy', addressed this issue by using an EUD4TEA-inclusive marker to track ion beam delivery. However, the original method had limitations in terms of radiation damage to surrounding tissue and accuracy of ion beam delivery. The new inventive concept builds upon the original patent by introducing optimized markers, real-time tracking, and dynamic ion beam intensity adjustment to further minimize radiation damage and enhance treatment accuracy.
Detailed Description of the Inventive Concept
The new inventive concept comprises a system for precise delivery of ion beam therapy, featuring a luminescence-based marker optimized for reduced radiation damage to surrounding tissue. The marker is designed to track ion beam delivery in real-time, allowing for dynamic adjustment of the ion beam trajectory and intensity. The system includes a novel triboluminescent material that emits light in response to ion beam impingement, which is detected by a sensor. This enables real-time monitoring of ion beam therapy and ensures accurate treatment. The inventive concept also encompasses methods for enhancing the accuracy of ion beam therapy, reducing radiation exposure, and providing real-time monitoring of ion beam therapy.
Novelty and Inventive Step
The new inventive concept introduces several novel and non-obvious features compared to the original patent, including optimized luminescence-based markers, real-time tracking, and dynamic ion beam intensity adjustment. These advancements enable more precise and efficient ion beam therapy, while minimizing radiation damage to surrounding tissue.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different luminescent materials, varying marker designs, or alternative detection methods. Additionally, the inventive concept could be adapted for use in other forms of radiation therapy, such as gamma knife therapy or proton therapy.
Potential Commercial Applications and Market
The enhanced luminescence-based method for precise delivery of ion beam therapy has significant commercial potential in the radiation oncology market, with potential applications in cancer treatment centers, hospitals, and research institutions. The inventive concept's ability to minimize radiation damage and enhance treatment accuracy makes it an attractive solution for healthcare providers seeking to improve patient outcomes.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Radiation Oncology and Medical Physics, focusing on targeted ion beam therapy and luminescence-based tracking technologies for cancer treatment
Person of Ordinary Skill (PHOSITA) Profile
A medical physicist or radiation oncology engineer with expertise in radiation delivery systems, advanced imaging techniques, and therapeutic marker technologies, holding advanced degrees in medical physics or biomedical engineering
Obviousness Rationale
A PHOSITA would recognize that the PTD represents a predictable extension of the source patent's core luminescence-based ion beam therapy methodology. The disclosed variations introduce incremental improvements in marker design, real-time tracking, and beam trajectory adjustment that would be considered routine optimization within the field. The technical solutions proposed represent logical refinements that would be apparent to a skilled practitioner seeking to enhance precision in radiation therapy delivery.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,806 |
|---|---|
| Title | Luminescence-based method for precise delivery of ion beam therapy |
| Assignee(s) | United States of America as represented by the Secretary of the Navy |